M. Zafar, MD, SC, is a leading internal medicine practice serving the Central Illinois community and beyond with offices in Streator and Flanagan. The practice is led by Muhammad Zafar, MD, who has over fifty years of experience working as a board-certified physician.

Dr. Zafar obtained his medical degree from King Edward Medical University in Lahore, Pakistan, in 1969. He completed his post-medical residency in Internal Medicine and fellowships in Hematology and Oncology at Cook County Hospital in Chicago, Illinois.

Patients trust Dr. Zafar because he has an extensive knowledge base and practical experience treating patients with various illnesses. M. Zafar, MD, SC, offers oncology care for blood cancers and other hematological malignancies. In addition to hematology, the practice provides medical weight loss support with Semaglutide (the active ingredient of Ozempic™ and Wegovy™) and Tirzepatide (the active ingredient of Mounjaro™). 

Dr. Zafar is a highly skilled physician who truly believes in being available to patients and their families. He is dedicated to staying up to date with trends in modern medicine to deliver patient care based on the latest research.

In his free time, Dr. Zafar enjoys watching the Chicago Bulls and Bears, gardening, and spending time with his grandchildren.

Revitalize your health journey with the comprehensive medical weight loss services at M. Zafar, MD, SC, serving Illinois statewide by Telehealth. Led by Dr. Muhammad Zafar, MD, the practice offers personalized and innovative weight loss strategies, including the use of Semaglutide (the active ingredient of Ozempic™ and Wegovy™) and Tirzepatide (the active ingredient of Mounjaro™). At M. Zafar, MD, SC, we strive to foster an environment where patients feel heard, understood, and confident in their health journey. Trust us to be your partner in health, paving the path to well-being through superior medical care.

• Insulin resistance is a serious health condition that can lead to type 2 diabetes, heart disease, and other chronic health problems. It is estimated that over 1 billion people worldwide have insulin resistance.

• Traditional treatments for insulin resistance focus on lowering blood sugar levels, but they do not address the underlying cause of the problem. AI-driven lifestyle modification is a new approach to reversing insulin resistance that is based on the latest scientific research.

• This approach uses artificial intelligence to create personalized plans for diet, exercise, and sleep that are designed to improve insulin sensitivity. These plans are based on each individual’s unique health data and lifestyle factors.

• Early studies have shown that AI-driven lifestyle modification can be an effective way to reverse insulin resistance and improve overall health. In one study, participants who followed an AI-driven lifestyle modification plan for six months were able to reduce their body fat by 5%, increase their muscle mass by 3%, and lower their blood sugar levels by 15%.

• AI-driven lifestyle modification is a safe and effective way to reverse insulin resistance and improve overall health. It is a personalized approach that is tailored to each individual’s needs.

Revolutionizing Health by Reclaiming Cardiometabolic Well-being.

Empowering people to take control of their chronic conditions through personalized digital therapeutics.

• Real-time data capture
• Integration with clinical workflows
• Focus on decision support
• Advanced analytics and reporting
• Interoperability with other healthcare systems

• Provider Focus
• Easy integration into existing apps/platforms
• Partnering model